Pharmaids Pharmaceuticals

Pharmaids Pharmaceuticals

62.00
-0.27
(-0.43%)
ann
There are 3 new updates from the company14 hours ago
Viewcross
right
Market Cap
218.65 Cr
EPS
-3.05
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
87.46
52 Week Low
31.90
PB Ratio
3.70
Debt to Equity
0.09
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,638.90
#1 3,93,227.01
34.30
#1 54,729.00
9.71
#1 10,980
-19.84
47.35
6,158.50
1,63,488.82
69.37
9,712.00
18.67
2,191
26.74
35.29
1,589.80
1,28,409.39
23.86
28,409.50
7.12
5,291
9.88
66.07
3,657.30
1,23,779.65
61.13
11,539.40
6.99
1,911
19.91
59.05
2,598.00
1,07,226.93
56.78
12,744.20
#1 20.90
2,007
-18.14
60.15
1,271.50
1,06,115.71
#1 18.75
33,741.20
16.73
5,725
1.26
57.30
992.70
99,888.85
21.29
23,511.00
18.55
4,615
2.60
56.17
1,970.50
89,991.84
24.22
22,909.50
13.74
3,306
#1 51.64
53.40
32,685.00
69,453.34
47.71
6,684.70
9.64
1,414
11.55
44.46
5,449.00
65,150.97
28.51
13,458.30
3.70
2,216
21.39
70.65
Forecast
Actual
Growth Rate
Revenue Growth
15.99 %
Net Income Growth
55.26 %
Cash Flow Change
-164.18 %
ROE
-50.06 %
ROCE
-60.04 %
EBITDA Margin (Avg.)
-

Quarterly Financial Results

Quarterly Financials
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
0
0
0
0
0
0
-0
1
6
5
5
5
5
7
Expenses
0
1
1
9
2
2
1
3
11
8
8
8
9
12
EBITDA
-0
-1
-1
-9
-1
-1
-1
-2
-6
-4
-3
-3
-4
-5
Operating Profit %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
-12,200 %
-96 %
-74 %
-50 %
-62 %
-82 %
-81 %
Depreciation
0
0
0
0
0
0
0
0
1
1
1
1
1
1
Interest
0
0
0
0
0
0
0
0
1
0
0
1
1
1
Profit Before Tax
-0
-1
-1
-9
-1
-1
-1
-2
-7
-4
-4
-4
-5
-7
Tax
0
0
0
-2
0
0
-1
-1
-1
-1
-1
-1
-1
-2
Net Profit
-0
-1
-1
-6
-1
-1
-1
-1
-6
-3
-3
-3
-5
-5
EPS in ₹
0.00
-0.05
-0.54
-4.76
-0.61
-0.61
-0.24
-0.54
-2.82
-0.76
-0.73
-0.55
-1.11
-1.41

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
11
25
91
120
Fixed Assets
0
0
63
50
Current Assets
3
18
14
22
Capital Work in Progress
0
2
7
5
Investments
0
3
0
12
Other Assets
11
19
21
0
Total Liabilities
11
25
91
120
Current Liabilities
2
2
12
29
Non Current Liabilities
0
0
9
36
Total Equity
9
23
71
59
Reserve & Surplus
-2
1
37
24
Share Capital
10
21
35
35

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
0
12
-8
Investing Activities
1
-5
-75
Operating Activities
-0
-4
-11
Financing Activities
0
21
78

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Jan 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
65.81 %
65.80 %
65.65 %
55.56 %
35.44 %
20.70 %
21.08 %
16.54 %
16.45 %
9.95 %
9.94 %
9.70 %
9.25 %
5.64 %
5.64 %
5.56 %
5.19 %
5.22 %
5.22 %
5.14 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
33.44 %
33.19 %
33.70 %
43.47 %
63.98 %
78.72 %
74.07 %
69.78 %
69.87 %
81.71 %
81.27 %
81.93 %
60.78 %
41.06 %
41.06 %
41.14 %
41.03 %
36.42 %
36.59 %
36.35 %
Others
0.74 %
1.01 %
0.65 %
0.97 %
0.58 %
0.57 %
4.84 %
13.68 %
13.68 %
8.34 %
8.79 %
8.37 %
29.96 %
53.30 %
53.30 %
53.29 %
53.78 %
58.37 %
58.20 %
58.51 %
No of Share Holders
5,861
7,192
7,331
8,314
9,620
9,495
9,193
8,862
8,196
7,761
7,476
7,393
7,281
7,554
7,567
7,594
8,050
8,349
8,220
8,026

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
31 Dec 2022 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
31 Dec 2022 18.95 28.00
31 Jan 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
31 Jan 2024 62.10 61.02
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2024 45.34 39.89
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 68.56 83.30
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 73.59 68.30
23 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 May 2025 67.93 67.72
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 63.22 63.49

Announcements

Announcement Under Reg 30(LODR) - Appointment Of Secretarial Auditor14 hours ago
Board Meeting Outcome for Outcome Of The Board Meeting Held On August 21 2025.14 hours ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 201122 hours ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report3 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)Aug 07, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 07, 2025
Unaudited Financial Results For The Quarter Ended June 30 2025.Aug 07, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Dated August 07 2025.Aug 07, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesAug 07, 2025
Updates on Open OfferAug 07, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June 2025.Aug 04, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesAug 01, 2025
Updates on Open OfferAug 01, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJul 30, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJul 25, 2025
Letter of OfferJul 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 15, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJul 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 04, 2025
Announcement under Regulation 30 (LODR)-Diversification / DisinvestmentJul 04, 2025
Outcome Of The Board MeetingJul 04, 2025
Closure of Trading WindowJun 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 24, 2025
Submission Of Audited Financial Results Along With Auditors Report For The Quarter And Year Ended 31St March 2025May 23, 2025
Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended March 31St 2025May 23, 2025
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended 31St March 2025.May 20, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 15, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Intimation Of Loan AgreementMar 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 26, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 26, 2025
Closure of Trading WindowMar 25, 2025
Intimation Under Regulation 8(2) Of SEBI (PIT) Regulation 2015 Regarding Amendment In Fair Disclosure CodeMar 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 20, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 19, 2025
Announcement Under Regulation 30 (LODR)- Intimation On Loan AgreementFeb 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationFeb 12, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 12, 2025
Integrated Filing (Financial)Feb 12, 2025
Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 12, 2025
Board Meeting Outcome for For Declaration Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024Feb 12, 2025
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024.Feb 07, 2025
Outcome Of The Circular Resolution Passed By The Board Of Directors Of The Company On February 06 2025Feb 06, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionFeb 05, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJan 10, 2025

Technical Indicators

RSI(14)
Neutral
46.93
ATR(14)
Less Volatile
3.41
STOCH(9,6)
Oversold
17.95
STOCH RSI(14)
Oversold
6.13
MACD(12,26)
Bearish
-0.35
ADX(14)
Weak Trend
14.74
UO(9)
Bearish
35.41
ROC(12)
Downtrend And Accelerating
-3.68
WillR(14)
Oversold
-81.86